Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.42+0.02 (+0.31%)
Close on Nov 13, 2026Market cap $243.02MP/E –Yield –
Lifecore Biomedical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Lifecore Biomedical's price to sales ratio was 1.9× on Nov 11, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 1.0× to 3.1×, with a median of 2.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | −0.5 |
| 2025 | Dec 31, 2025 | 2.4× | +0.6 |
| 2024 | Dec 31, 2024 | 1.8× | −0.0 |
| 2023 | Dec 29, 2023 | 1.8× | +0.1 |
| 2022 | Dec 30, 2022 | 1.7× | −1.0 |
| 2021 | Dec 31, 2021 | 2.8× | +2.1 |
| 2020 | Dec 31, 2020 | 0.7× | +0.1 |
| 2019 | Dec 31, 2019 | 0.6× | −0.0 |
| 2018 | Dec 31, 2018 | 0.6× | −0.1 |
| 2017 | Dec 29, 2017 | 0.7× | −0.0 |
| 2016 | Dec 30, 2016 | 0.7× | +0.1 |
| 2015 | Dec 31, 2015 | 0.6× | −0.1 |
| 2014 | Dec 31, 2014 | 0.7× | +0.0 |
| 2013 | Dec 31, 2013 | 0.7× | +0.0 |
| 2012 | Dec 31, 2012 | 0.7× | +0.2 |
| 2011 | Dec 30, 2011 | 0.5× | +0.5 |
| 2010 | Dec 31, 2010 | 0.0× | – |
See a number that looks wrong?